White Pine Capital’s Apyx Medical APYX Stock Holding History

White Pine Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-99,974	Closed	-$449K	–	201
2022 Q3	$449K	Buy	99,974 +86,724	+655%	+$621K	0.19%	126
2022 Q2	$78K	Sell	13,250 -520	-4%	-$2.67K	0.03%	206
2022 Q1	$90K	Sell	13,770 -31,363	-69%	-$309K	0.03%	218
2021 Q4	$579K	Sell	45,133 -12,045	-21%	-$168K	0.17%	146
2021 Q3	$792K	Sell	57,178 -471	-0.8%	-$4.95K	0.24%	122
2021 Q2	$519K	Sell	57,649 -23,329	-29%	-$231K	0.15%	154
2021 Q1	$782K	Sell	80,978 -511	-0.6%	-$5.11K	0.25%	121
2020 Q4	$587K	Buy	81,489 +46,394	+132%	+$307K	0.21%	130
2020 Q3	$165K	Buy	+35,095	New	+$174K	0.07%	205
2019 Q1	–	Sell	-10,200	Closed	-$66K	–	227
2018 Q4	$66K	Sell	10,200 -139,790	-93%	-$847K	0.03%	206
2018 Q3	$1.06M	Sell	149,990 -118,500	-44%	-$659K	0.38%	80
2018 Q2	$1.17M	Buy	268,490 +1,465	+0.5%	+$5.41K	0.42%	74
2018 Q1	$793K	Buy	267,025 +13,700	+5%	+$35.3K	0.29%	106
2017 Q4	$659K	Buy	+253,325	New	+$791K	0.24%	123

Other funds holding APYX

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

White Pine Capital's APYX Position: Q4 2022 in Review

White Pine Capital sold out of Apyx Medical (APYX) in Q4 2022, closing a stake of 99,974 shares — an estimated $449K sold.

White Pine Capital first reported a position in APYX in Q4 2017 and held it in 14 quarters. The position peaked at $1.17M in Q2 2018. 50 funds tracked by Wall St. Rank hold APYX as of Q4 2022.

White Pine Capital reported no remaining Apyx Medical position as of Q4 2022 after selling out during the quarter.
White Pine Capital sold 99,974 Apyx Medical shares in Q4 2022, an estimated $449K.
White Pine Capital first reported a position in Apyx Medical in Q4 2017 and held it in 14 quarters.
White Pine Capital's Apyx Medical position peaked at $1.17M in Q2 2018.
50 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2022.

Based on White Pine Capital's 13F filing for Q4 2022, filed 10 Feb 2023.